Evidence map›Paper›PMID 39768153›Full record

ArticleCells2024

Inflammatory Response of THP1 and U937 Cells: The RNAseq Approach.

Layla Panahipour, Chiara Micucci, Reinhard Gruber

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Layla PanahipourDepartment of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-3557-3493
Chiara MicucciDepartment of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, 1090 Vienna, Austria.
Reinhard GruberDepartment of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, 1090 Vienna, Austria.

Funding

International Team for Implantology 1709-2022International Team for Implantology 1729-2023
6 · The paper itself

Abstract

THP1 and U937 are monocytic cell lines that are common bioassays to reflect monocyte and macrophage activities in inflammation research. However, THP-1 is a human monocytic leukemia cell line, and U937 originates from pleural effusion of histiocytic lymphoma; thus, even though they serve as bioassay in inflammation research, their response to agonists is not identical. Consequently, there has yet to be a consensus about the panel of strongly regulated genes in THP1 and U937 cells representing the inflammatory response to LPS and IFNG. Therefore, we have performed an RNAseq of THP1 and U937 exposed to LPS and IFNG to identify the most sensitive genes and the unique properties of each individual cell line. When applying a highly stringent threshold, we could identify 43, 8 up and 94, 103 down-regulated genes in THP1 and U937 cells, respectively. In THP1 cells, among the most strongly up-regulated genes are

Indexed as

InflammationLipopolysaccharidesGene Expression ProfilingGene Expression RegulationHumansInterferon-gammaMonocytesSequence Analysis, RNATHP-1 CellsU937 CellsInterferon-gammaLipopolysaccharidesbioassayIFNGinflammationLPSmacrophagesRNAseqTHP1U937

Identifiers

PMID39768153
PMCPMC11674919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.